ClinicalTrials.Veeva

Menu

Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients (PEPITS)

R

Regional University Hospital Center (CHRU)

Status

Enrolling

Conditions

Schizophrenia

Treatments

Other: Usual care
Diagnostic Test: PEPITS Programme

Study type

Interventional

Funder types

Other

Identifiers

NCT05329363
DR190062

Details and patient eligibility

About

Schizophrenia affects about 0.7% of the population. Poor insight, which is common in this disease, linked to poor drug compliance is leads to rehospitalisation with major impact on quality of life. Indeed, many patients relapse with exacerbation of symptoms.

Psychoeducation can improve therapeutic alliance and medication compliance.

In this context, an individual psycho-education program (PEPITS) has been developed. PEPITS carried out by nurses during the initial stages of hospitalisation.

The hypothesis is that PEPITS program will decrease relapse and improve the compliance and insight and and so the quality of life.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 65 years

  • Patient with a diagnosed and reported schizophrenic disorder announced :

    • Schizophrenia
    • Schizoaffective disorder
  • Or a diagnosed and reported Delusional Disorder

  • Express written consent by the participant after receiving information about the study

  • Be able to communicate verbally

  • Participant affiliated to a social security scheme

Exclusion criteria

  • Pregnant or breastfeeding woman
  • Patient who does not speak French
  • Participation in a psycho-education group in the last 2 years
  • Patient under legal protection or guardianship

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

PEPITS programme
Experimental group
Treatment:
Diagnostic Test: PEPITS Programme
Usual care
Active Comparator group
Treatment:
Other: Usual care

Trial contacts and locations

11

Loading...

Central trial contact

Marie LECLERC; Arnaud CHESSE

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems